All News

New Strategy for Drug Design: Keeping Copper Atoms Closer to Keep Bacteria Away
Ref: Tokyo University of Science
Tags: Press ReleaseBacterial Infections Clinical Research (R&D)
Granules India reports Income from operations at INR 850 Cr up 16% YoY, EBITDA at INR 201 Cr, EBITDA Margin at 24% PAT at INR 120 Cr, up 8% YoY
Ref: Granules India
Tags: Press ReleaseGranules Corporate Affairs
Arena Pharmaceuticals and Aristea Therapeutics Establish Collaboration for Development of RIST4721 for Treatment of Serious Immune-Mediated Inflammatory Diseases
Ref: Business Wire
Tags: Press ReleaseArena Pharmaceuticals Aristea Therapeutics Corporate Affairs Licensing Mergers & AcquisitionsRIST4721
Caribou Biosciences Announces Closing of Upsized Initial Public Offering
Ref: Business Wire
Tags: Press ReleaseCaribou Biosciences Corporate Affairs
AzurRx BioPharma Announces Closing of $5.75 Million Bought Deal Offering and Exercise in Full of Underwriter’s Option to Purchase Additional Shares
Ref: GlobeNewswire
Tags: Press ReleaseAzurRX Biopharma Corporate Affairs
Cybin Announces Overnight Marketed Public Offering of Common Shares
Ref: Business Wire
Tags: Press ReleaseCybin Corporate Affairspsilocybin
Abzena and BioXpress Therapeutics announce partnership to support the development and manufacture of biosimilars for global customers.
Ref: Abzena
Tags: Press ReleaseAbzena BioXpress Therapeutics Corporate Affairs
Patients with advanced bladder cancer could benefit from immunotherapy regardless of gene mutation status
Ref: UNC Lineberger Comprehensive Cancer Center
Tags: Press ReleaseBladder Cancer Clinical Research (R&D)Balversa
New breakthrough to help immune systems in the fight against cancer
Ref: University of Southampton
Tags: Press Release Clinical Research (R&D)
New Approach for Cell Therapy Shows Potential Against Solid Tumors with KRAS Mutations
Ref: University of Pennsylvania School of Medicine
Tags: Press ReleaseLung Cancer Pancreatic Cancer Colorectal Cancer Clinical Research (R&D)